Table 1.
Medicine | Medicine class | Administration route | Dosing frequency | Complexity |
---|---|---|---|---|
Sildenafil | PDE5i | Oral tablet | Three times daily | |
Tadalafil | PDE5i | Oral tablet | Once daily | |
Bosentan | ERA | Oral tablet | Twice daily | Requires monthly blood test for liver function |
Ambrisentan | ERA | Oral tablet | Once daily | Requires monthly blood test for liver function |
Macitentan | ERA | Oral tablet | Once daily | Requires monthly blood test for liver function |
Iloprost | Prostanoid | Nebulizer | Seven times a day (every 3 h while awake) | Nebulizer set-up and frequent cleaning |
Epoprostenol | Prostanoid | Intravenous (IV) infusion | Continuous infusion changed 12–48 hourly | IV line care and multiple step reconstitution process |
Treprostinil | Prostanoid | Nebulizer, IV or subcutaneous (SC) | Four times a day nebulizer, continuous IV or SC infusion | Nebulizer set-up and frequent cleaning, IV line care, SC site care |
Selexipag | IPRA | Oral tablet | Twice daily | |
Riociguat | SGCS | Oral tablet | Three times daily |
PDE5i, phosphodiesterase type-5 inhibitor; ERA, endothelin antagonist; IPRA, IP receptor agonist; SGCS, soluble guanylate cyclase stimulator.